DexCom
DXCM
#904
Rank
A$39.23 B
Marketcap
A$101.67
Share price
2.17%
Change (1 day)
-23.91%
Change (1 year)

Earnings for DexCom (DXCM)

Earnings in 2026 (TTM): A$1.82 Billion

According to DexCom's latest financial reports the company's current earnings are A$4.81 Billion. In 2025 the company made an earning of A$1.60 Billion, an increase over its 2024 earnings that were of A$1.05 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for DexCom from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$1.82 B13.61%
2025 A$1.60 B52.02%
2024 A$1.05 B-0.37%
2023 A$1.05 B78.13%
2022 A$0.59 B47.34%
2021 A$0.40 B-10.11%
2020 A$0.44 B88.27%
2019 A$0.23 B-258.48%
2018 -A$0.16 Billion189.94%
2017 -A$51.9 Million-44.24%
2016 -A$93.06 Million12.43%
2015 -A$82.77 Million165.58%
2014 -A$31.17 Million-25.61%
2013 -A$41.9 Million-48.11%
2012 -A$80.74 Million24.5%
2011 -A$64.85 Million
2008 -A$76.58 Million13.18%
2007 -A$67.66 Million-5.36%
2006 -A$71.49 Million52.08%
2005 -A$47.01 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$37.65 B 2,028.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$11.79 B 566.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
A$9.09 B 414.30%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Becton Dickinson
BDX
A$2.85 B 61.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Edwards Lifesciences
EW
A$1.87 B 5.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
-A$0.3 Billion-116.41%๐Ÿ‡บ๐Ÿ‡ธ USA
QuidelOrtho
QDEL
-A$1.65 Billion-193.11%๐Ÿ‡บ๐Ÿ‡ธ USA
West Pharmaceutical Services
WST
A$0.97 B-45.05%๐Ÿ‡บ๐Ÿ‡ธ USA